chemotherapy arm of the CheckMate-8HW trial showed that the combination regimen reduced the risk of cancer progression or death by 79% compared to chemotherapy in first-line patients. This arm ...

Its incidence in the general population is 0.5%. In cardiac surgery patients, it is suspected when using the left subclavian vein or left internal jugular vein for central venous catheter or ...

Herein we report a case of 62-year-old male diagnosed with liver metastatic HAS, who progressed rapidly after first-line cisplatin + fluorouracil chemotherapy combined with pembrolizumab. However, the ...

their families and health-care providers are benefiting from the most possible and the best use of resources directed to front-line patient care,” she says in the news release. The release says ...

TACTI-004 will evaluate Immutep’s eftilagimod alfa, a first-in-class MHC Class II agonist, in combination with Merck & Co’s anti-PD-1 therapy Keytruda (pembrolizumab) and chemotherapy as first line ...

Bottom line: Vitamin A isn’t going to prevent someone from getting the measles, and it’s also not proven to help with symptoms for patients who aren’t hospitalized, according to Patel. Ingesting high ...

Plan to advance amezalpat into a registrational study in first-line liver cancer patients, subject to obtaining additional resources. TPST-1495 (clinical dual EP2/4 prostaglandin receptor ...

The Phase 3, randomized, double-blind, placebo-controlled multicenter study (NCT05263999) compared the efficacy and safety of intravenous administered itolizumab versus placebo (randomized 1:1) as a ...

Therefore, we present a case of a patient diagnosed with advanced PM who was treated with three lines of therapy, including antiangiogenic agent in the second line and immunotherapy with pembrolizumab ...

Our extensive list of publications below is grouped within categories to make it easier to find the right information. You can see the whole list of booklets and factsheets if you click the ‘Expand ...